About ClarityAccessHub
ClarityAccessHub is operated by leaders with operational depth in anti-amyloid therapy delivery, specialty infusion, and the AD-specific clinical and compliance architecture the category requires.
Our Mission
Therapies that work but don't reach patients aren't truly therapies — they're potential. ClarityAccessHub exists to convert that potential into patient access for AD specifically, by operationalizing the infrastructure anti-amyloid therapy requires. ClarityAccessHub is currently focused exclusively on operational coordination for anti-amyloid therapy delivery.
Every architectural decision serves a single goal: getting anti-amyloid therapy to the AD patients who need it. When patient access conflicts with operational convenience or commercial preference, patient access wins.
Manufacturer relationships are structured as bona fide commercial agreements under established legal frameworks. Compliance is built into the architecture — bucket separation, FMV documentation, quarterly certifications — not bolted on.
ClarityAccessHub partners across the anti-amyloid manufacturer landscape. No exclusivity, no favoritism. The patient access mission is incompatible with locking ClarityAccessHub's infrastructure to a single drug or a single sponsor.
ClarityAccessHub is purpose-built for anti-amyloid therapy delivery. The qualification, ARIA monitoring, registry, and coordination workflow embedded in the Memory Rx Toolkit are designed around AD specifically — not retrofitted from a generic specialty drug model.
Leadership and Clinical Advisory
Founding Partner at BUILD Capital Partners. Co-founder of PURE Healthcare. Contributor to McKesson's Alzheimer's Playbook.
Founding Partner at BUILD Capital Partners. Co-founder of PURE Healthcare. Strategic lead on ClarityAccessHub's go-to-market, platform development, and manufacturer engagement.
Neurologist at Memory Treatment Centers. First-commercial Leqembi and Kisunla treating physician. Contributor to McKesson's Alzheimer's Playbook. Co-architect of the qualification protocol used across the Memory Rx Toolkit.
Neurologist and co-founder of Memory Treatment Centers. Builder of the mini-fellowship that trains nurse practitioners in cognitive qualification within 90 days.
Neurologist at Memory Treatment Centers. Clinical advisor on qualification, ARIA management, and adherence protocols.
For manufacturer partnerships, provider membership inquiries, or general questions about ClarityAccessHub and the Memory Rx Toolkit.
hello@clarityaccesshub.com